January 2025 begins a new year and offers opportunities to connect with investors and strategic partners. AZBio leaders will be in San Francisco to make new connections and reconnect with standing partners. If you are going to San Francisco, let us know so we can help you make the most of your JPM Week experience. We're also compiling a list of resources you can explore. Check them out.
From January 12 - January 16, 2025 one of the largest and most influential gatherings in the healthcare and life sciences industry executives will take place in San Francisco.
State Bio Friends Kickoff 2025
We’re kicking off JPM Healthcare Week 2025 in style.
Sunday, January 12, 2025
04:00 PM – 07:00 PM
The Marker San Francisco
Learn More
This is an invite only event. AZBio Members will find their access code on IN THE LOOP.
BIO Partnering @JPM Week
BIO has secured space at the San Francisco Marriott Marquis during JPM Week, giving you a centrally-located home base for in-person meetings.
In addition, BIO One-on-One gives you the flexibility to meet at your own in-person location, virtually via a BIO link, or within your own virtual meeting platform.
LSN Hotel List
Finding a place to stay during JPM can be daunting. Fortunately, there are still nearly 30 hotels in downtown San Fran under $500 per night! Find the hotel list below to see which hotels have vacancy and what their prices are.
RESI JPM 2025
The 50th RESI Conference will be held on January 14 at the San Francisco Marriott Marquis, featuring an in-person event followed by two days of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 500 early-stage life science investors, innovators, and industry experts.
Contact Erika Wu to learn about opportunities for AZBio Members.
BIOTECH SHOWCASE 2025
January 13–15, 2025 | Hilton Union Square | San Francisco, CA,
January 21–22, 2025 | Virtual
Biotech Showcase, along with its family of events, Seed Showcase and TechBio Showcase, is a dedicated investor conference designed to provide private and micro-mid-cap biotechnology companies with the opportunity to present to and connect with investors and biopharmaceutical executives.